Actively Recruiting
Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy
Led by Sahiwal medical college sahiwal · Updated on 2024-12-18
140
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
Sponsors
S
Sahiwal medical college sahiwal
Lead Sponsor
D
Department of medical education
Collaborating Sponsor
AI-Summary
What this Trial Is About
Nowadays laparoscopic surgery is the first choice for many surgeries. Such surgeries have revolutionized the surgical practice and has markedly reduced the incidence of intraoperative and postoperative complications. To minimize these side effects associated with the use of opioids, various methods have been adopted. Recently, different trials have highlighted the possible role of dexmedetomidine and lignocaine in providing postoperative analgesia and attenuating hemodynamic response. Literature showed conflicting results regarding both these drugs. So, we want to find the evidence for local setting. This Randomized Controlled Trial will be done at Department of Anesthesia, Sahiwal teaching hospital, Sahiwal for 12 months. Sample size of 140 cases; 70 cases in each group will be included through non-probability consecutive sampling. Then patients will be divided in two groups by using computer generated random number table. In group A, patients will be given dexmedetomidine infusion. In group B, patients will be given lignocaine infusion. All anesthesia procedures will be done by researcher. Heart rate and mean arterial pressure will be assessed before induction of anesthesia, after every 10 mins every 30 mins till completion of surgery. Total operative time will be noted. After procedure, patients will be assessed for postoperative pain score. when pain will be ≥4 on visual analogue scale rescue analgesia will be given and time will be noted. Total duration from time of surgery till need for rescue analgesia will be noted. Duration of postoperative analgesia opioid consumption /24 hrs.) will be presented by using mean± SD.
CONDITIONS
Official Title
Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 20 to 70 years
- Both genders
- Undergoing laparoscopic cholecystectomy under general anesthesia
- ASA physical status I or II
You will not qualify if you...
- Emergency surgery
- History of allergic reaction to dexmedetomidine or lignocaine
- Cardiovascular disease, sickle cell disease, psychiatric disorder, peripheral vascular disease, or neurological diseases
- Anemia
- Use of tricyclic antidepressants or beta blocker drugs
- Uncontrolled hypertension (blood pressure 60/100 mmHg)
- Uncontrolled diabetes mellitus
- Obesity with body mass index greater than 35
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sahiwal Medical College Sahiwal
Sahiwal, Punjab Province, Pakistan, 57000
Actively Recruiting
Research Team
T
Tallal Shahid, MBBS
CONTACT
D
Dr Muhammad Shahid, FCPS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here